Literature DB >> 27881150

A metadata schema for data objects in clinical research.

Steve Canham1, Christian Ohmann2.   

Abstract

BACKGROUND: A large number of stakeholders have accepted the need for greater transparency in clinical research and, in the context of various initiatives and systems, have developed a diverse and expanding number of repositories for storing the data and documents created by clinical studies (collectively known as data objects). To make the best use of such resources, we assert that it is also necessary for stakeholders to agree and deploy a simple, consistent metadata scheme.
METHODS: The relevant data objects and their likely storage are described, and the requirements for metadata to support data sharing in clinical research are identified. Issues concerning persistent identifiers, for both studies and data objects, are explored.
RESULTS: A scheme is proposed that is based on the DataCite standard, with extensions to cover the needs of clinical researchers, specifically to provide (a) study identification data, including links to clinical trial registries; (b) data object characteristics and identifiers; and (c) data covering location, ownership and access to the data object. The components of the metadata scheme are described.
CONCLUSIONS: The metadata schema is proposed as a natural extension of a widely agreed standard to fill a gap not tackled by other standards related to clinical research (e.g., Clinical Data Interchange Standards Consortium, Biomedical Research Integrated Domain Group). The proposal could be integrated with, but is not dependent on, other moves to better structure data in clinical research.

Entities:  

Keywords:  Data repositories; Data sharing; ECRIN; European Clinical Research Infrastructure Network; Identifiers; Metadata; Standards; Transparency

Mesh:

Year:  2016        PMID: 27881150      PMCID: PMC5122021          DOI: 10.1186/s13063-016-1686-5

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


  13 in total

1.  Registration practices for observational studies on ClinicalTrials.gov indicated low adherence.

Authors:  Stefania Boccia; Kenneth J Rothman; Nikola Panic; Maria Elena Flacco; Annalisa Rosso; Roberta Pastorino; Lamberto Manzoli; Carlo La Vecchia; Paolo Villari; Paolo Boffetta; Walter Ricciardi; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2015-09-18       Impact factor: 6.437

2.  Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors.

Authors:  Darren B Taichman; Joyce Backus; Christopher Baethge; Howard Bauchner; Peter W de Leeuw; Jeffrey M Drazen; John Fletcher; Frank A Frizelle; Trish Groves; Abraham Haileamlak; Astrid James; Christine Laine; Larry Peiperl; Anja Pinborg; Peush Sahni; Sinan Wu
Journal:  JAMA       Date:  2016-02-02       Impact factor: 56.272

3.  A Global, Neutral Platform for Sharing Trial Data.

Authors:  Barbara E Bierer; Rebecca Li; Mark Barnes; Ida Sim
Journal:  N Engl J Med       Date:  2016-05-11       Impact factor: 91.245

4.  The ClinicalTrials.gov results database--update and key issues.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

5.  Reducing waste from incomplete or unusable reports of biomedical research.

Authors:  Paul Glasziou; Douglas G Altman; Patrick Bossuyt; Isabelle Boutron; Mike Clarke; Steven Julious; Susan Michie; David Moher; Elizabeth Wager
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

6.  "Hardly worth the effort"? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study.

Authors:  Elizabeth Wager; Peter Williams
Journal:  BMJ       Date:  2013-09-06

7.  Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results.

Authors:  Vasee S Moorthy; Ghassan Karam; Kirsten S Vannice; Marie-Paule Kieny
Journal:  PLoS Med       Date:  2015-04-14       Impact factor: 11.069

8.  OpenTrials: towards a collaborative open database of all available information on all clinical trials.

Authors:  Ben Goldacre; Jonathan Gray
Journal:  Trials       Date:  2016-04-08       Impact factor: 2.279

9.  Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration.

Authors:  Amelia Scott; Julia J Rucklidge; Roger T Mulder
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  Sharing raw data from clinical trials: what progress since we first asked "Whose data set is it anyway?".

Authors:  Andrew J Vickers
Journal:  Trials       Date:  2016-05-04       Impact factor: 2.279

View more
  4 in total

1.  Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science.

Authors:  Joan E Adamo; Robert V Bienvenu Ii; Felipe Dolz; Michael Liebman; Wendy Nilsen; Scott J Steele
Journal:  Digit Biomark       Date:  2020-02-07

2.  Schema Playground: A tool for authoring, extending, and using metadata schemas to improve FAIRness of biomedical data.

Authors:  Marco Cano; Ginger Tsueng; Xinghua Zhou; Laura D Hughes; Julia L Mullen; Jiwen Xin; Andrew I Su; Chunlei Wu
Journal:  bioRxiv       Date:  2022-06-02

Review 3.  Sharing individual participant data: through a systematic reviewer lens.

Authors:  Larysa H M Rydzewska; Lesley A Stewart; Jayne F Tierney
Journal:  Trials       Date:  2022-02-21       Impact factor: 2.728

4.  Sharing and reuse of individual participant data from clinical trials: principles and recommendations.

Authors:  Christian Ohmann; Rita Banzi; Steve Canham; Serena Battaglia; Mihaela Matei; Christopher Ariyo; Lauren Becnel; Barbara Bierer; Sarion Bowers; Luca Clivio; Monica Dias; Christiane Druml; Hélène Faure; Martin Fenner; Jose Galvez; Davina Ghersi; Christian Gluud; Trish Groves; Paul Houston; Ghassan Karam; Dipak Kalra; Rachel L Knowles; Karmela Krleža-Jerić; Christine Kubiak; Wolfgang Kuchinke; Rebecca Kush; Ari Lukkarinen; Pedro Silverio Marques; Andrew Newbigging; Jennifer O'Callaghan; Philippe Ravaud; Irene Schlünder; Daniel Shanahan; Helmut Sitter; Dylan Spalding; Catrin Tudur-Smith; Peter van Reusel; Evert-Ben van Veen; Gerben Rienk Visser; Julia Wilson; Jacques Demotes-Mainard
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.